Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “dcSSc”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05626751
What this trial is testing

An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerosis, Systemic
Amgen 174
Testing effectiveness (Phase 2)Study completedNCT02921971
What this trial is testing

Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sanofi 97
Testing effectiveness (Phase 2)Ended earlyNCT03919799
What this trial is testing

KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
System; SclerosisDiffuse Cutaneous Systemic Sclerosis
Kadmon, a Sanofi Company 36
Large-scale testing (Phase 3)UnknownNCT01586663
What this trial is testing

Serial Night Time Position Splint on Systemic Sclerosis

Who this might be right for
Diffuse Systemic Sclerosis
Federal University of São Paulo 76
Early research (Phase 1)Study completedNCT00433186
What this trial is testing

Mycophenolate Mofetil in Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Boston University 30
Early research (Phase 1)Ended earlyNCT00418132
What this trial is testing

Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
NYU Langone Health 30
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Not applicableStudy completedNCT01093885
What this trial is testing

Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis

Who this might be right for
Systemic SclerosisScleroderma
University of Pennsylvania 15
Testing effectiveness (Phase 2)Ended earlyNCT02465437
What this trial is testing

Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Corbus Pharmaceuticals Inc. 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT06655896
What this trial is testing

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Diffuse
Novartis Pharmaceuticals 96
Testing effectiveness (Phase 2)Study completedNCT04440592
What this trial is testing

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Tanabe Pharma America, Inc. 76
Early research (Phase 1)Study completedNCT01284322
What this trial is testing

Fresolimumab In Systemic Sclerosis

Who this might be right for
Diffuse Systemic Sclerosis
Boston University 18
Early research (Phase 1)Ended earlyNCT04948554
What this trial is testing

MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)

Who this might be right for
Systemic Sclerosis With and Without Interstitial Lung Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 5
Not applicableWithdrawnNCT02531009
What this trial is testing

Systemic Sclerosis Clinical and Biomarker Study

Who this might be right for
HealthySystemic Sclerosis
Biogen
Early research (Phase 1)Study completedNCT03831438
What this trial is testing

Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Diffuse
Bristol-Myers Squibb 9
Early research (Phase 1)Looking for participantsNCT06708845
What this trial is testing

US Zamto-cel Autoimmune Diseases

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSystemic Sclerosis (SSc)+1 more
Miltenyi Biomedicine GmbH 48
Testing effectiveness (Phase 2)Looking for participantsNCT05149768
What this trial is testing

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Early research (Phase 1)Looking for participantsNCT06414135
What this trial is testing

Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Liangjing Lu 6
Testing effectiveness (Phase 2)Study completedNCT03198689
What this trial is testing

Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Testing effectiveness (Phase 2)Study completedNCT00016458
What this trial is testing

Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Fred Hutchinson Cancer Center 20
Next Page